Cadrenal Therapeutics launches partnership process for cardiac critical care assets
Cadrenal announced a strategic partnering process for its cardiology assets following positive Phase 2 data presentation and reorganization of its portfolio into a dedicated franchise.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day